entertainment -WSS

entertainment

author：entertainment 2025-10-01 10:58:37 - browse：695

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Influencer to be charged after chaos erupts in New York City's Union Square

WSS

Pancreatic cancer is often deadly, but new discoveries are raising hope

Overprescribed: High cost isn't America's only drug problem

ER docs worry over extreme heat as a 'mass casualty event'

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

A cyberattack has disrupted hospitals and health care in several states

2 US Navy sailors arrested for allegedly spying for China

hotspot

entertainment

explore

Sports medicine is finally prioritizing gender equality

What Henrietta Lacks settlement says about racism in medicine

Jerome Adams on the need for new antivirals for Covid

Gut bacteria may contribute to kidney autoimmunity, study finds

In Memoriam: Notable people who died in 2023

ER docs worry over extreme heat as a 'mass casualty event'

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Medical leaders decry Supreme Court decision on affirmative action

Overprescribed: High cost isn't America's only drug problem

focus

First Opinion on colorectal cancer screening: letter and response

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Republican states more likely to report Covid vaccine side effects

Attacks on the drug industry will lead to fewer breakthroughs

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

focus

hotspot

leisure time